Soleno Therapeutics, Inc. ( SLNO) - Key Metrics
Stock symbol SLNO is outdated, potentially delisted? Maybe it is available on other exchange?
SLNO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.73 | $0.82 | $0.92 | $0.91 |
| 2025Q3 | $1.24 | $0.49 | $0.82 | $0.82 |
| 2025Q2 | $0.65 | -$0.09 | -$0.25 | -$0.25 |
| 2025Q1 | ? | -$0.95 | -$0.71 | -$0.71 |
SLNO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 14.20 |
| 2025Q3 | ? | 34.65 |
| 2025Q2 | ? | -224.59 |
| 2025Q1 | ? | -18.84 |
SLNO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.49% | ? |
| 2025Q4 | 1.98% | ? |
| 2025Q3 | 1.21% | ? |
| 2025Q2 | -0.30% | ? |
| 2025Q1 | -0.99% | ? |
SLNO
Price: $53.01
52 week price:
Earnings Per Share: 1.93 USD
P/E Ratio: 27.47
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 110100
Ebitda: -13.8 millionMarket Capitalization: 2.8 billion